$21.98
0.00 (0%)
IMS Health, Inc. (NYSE:RX.DL)
CAPS Rating:
The Company provides critical business intelligence, including information, analytics and consulting services to the pharmaceutical and healthcare industries worldwide.
RSS Headlines
Fool UK
Recs
Currently undervalued. Wide moat: information on drug sales from wide variety of sources. Pharma companies have temporarily cut back on IMS's services, but longer term will have to come back to them.